Evidence for choosing biologic disease-modifying anti-rheumatic drugs in the treatment of Behçet disease
- PMID: 28413101
- DOI: 10.1016/j.semarthrit.2017.03.017
Evidence for choosing biologic disease-modifying anti-rheumatic drugs in the treatment of Behçet disease
Comment on
-
Tocilizumab in severe and refractory Behcet's disease: Four cases and literature review.Semin Arthritis Rheum. 2016 Jun;45(6):733-7. doi: 10.1016/j.semarthrit.2015.11.012. Epub 2015 Dec 2. Semin Arthritis Rheum. 2016. PMID: 26743073 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
